The United States Dendritic Cell Cancer Vaccine Market holds the largest single-country share in the region, propelled by an established clinical foundation, high healthcare expenditure, and major medical centers specializing in advanced precision oncology. The market is supported by commercial availability and steady hospital utilization of FDA-approved cell-based immunotherapies such as...